Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie's New Lung Cancer Drug May Extend Patients' Lives, But Could Disappoint Investors
AbbVie's New Lung Cancer Drug May Extend Patients' Lives, But Could Disappoint Investors
AbbVie's New Lung Cancer Drug May Extend Patients' Lives, But Could Disappoint Investors
Submitted by
admin
on June 5, 2016 - 11:50am
Source:
Forbes
News Tags:
AbbVie
Rova-T
non-small cell lung cancer
ASCO 2016
Headline:
AbbVie's New Lung Cancer Drug May Extend Patients' Lives, But Could Disappoint Investors
Do Not Allow Advertisers to Use My Personal information
